title: Looking at Biotech's Crystal Ball: The issues we'll be focused on in 2005.
abstract: Biotech's course through 2005 will hinge on five key variables: Use of electronic medical records to speed data collectionClarifying sources of investment capitalKeeping clinicians currentReshaping benefit designs to cope with new and costly productsAnd, above all, defining and proving the value of biotech products Here's a look at how these issues could play out in the year ahead.
authors: Scott
authors: S
authors: Kober